pimobendan has been researched along with Heart Valve Diseases in 8 studies
pimobendan: produces arterial & venous dilatation in dogs; structure given in first source
Heart Valve Diseases: Pathological conditions involving any of the various HEART VALVES and the associated structures (PAPILLARY MUSCLES and CHORDAE TENDINEAE).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pimobendan has gained enormous importance in the treatment of mitral valve disease in dogs." | 6.90 | Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly. ( Bach, JP; Iwanuk, N; Nolte, I; Pilgram, A; Raue, J; Rohn, K; Rumstedt, K; Sehn, M; Wall, L, 2019) |
| "Pimobendan is a widely used medication for the treatment of dogs with congestive heart failure (CHF) and preclinical degenerative mitral valve disease (DMVD) with cardiomegaly." | 3.01 | The effect of treatment with pimobendan in dogs with preclinical mitral valve disease - a placebo-controlled double-blinded crossover study. ( Bach, JP; Beyerbach, M; Klein, S; Nolte, I; Raue, JF; Rumstedt, K; Sehn, M; Treese, JS; Weiner, F, 2021) |
| "Pimobendan has gained enormous importance in the treatment of mitral valve disease in dogs." | 2.90 | Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly. ( Bach, JP; Iwanuk, N; Nolte, I; Pilgram, A; Raue, J; Rohn, K; Rumstedt, K; Sehn, M; Wall, L, 2019) |
| "Pimobendan is a phosphodiesterase III inhibitor with positive inotropic and vasodilator effects." | 1.56 | Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease. ( Bode, EF; Dukes-McEwan, J; Hodgkiss-Geere, HM; Maddox, TW; Neves, J; Sarcinella, F, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 4 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Klein, S | 1 |
| Nolte, I | 3 |
| Rumstedt, K | 3 |
| Sehn, M | 3 |
| Raue, JF | 1 |
| Weiner, F | 1 |
| Treese, JS | 1 |
| Beyerbach, M | 1 |
| Bach, JP | 3 |
| Kaplan, JL | 2 |
| Visser, LC | 2 |
| Gunther-Harrington, CT | 1 |
| Ontiveros, ES | 1 |
| Wittenburg, LA | 1 |
| Palm, CA | 1 |
| Stern, JA | 1 |
| Ellis-Reis, RE | 1 |
| Hsue, W | 1 |
| Sharpe, AN | 1 |
| Iwanuk, N | 2 |
| Wall, L | 2 |
| Raue, J | 2 |
| Pilgram, A | 2 |
| Rohn, K | 1 |
| Sarcinella, F | 1 |
| Neves, J | 1 |
| Maddox, TW | 1 |
| Hodgkiss-Geere, HM | 1 |
| Bode, EF | 1 |
| Dukes-McEwan, J | 1 |
| McNaughton, A | 1 |
| Frasca, S | 1 |
| Mishra, N | 1 |
| Tuttle, AD | 1 |
| Boswood, A | 1 |
| McEwan, JD | 1 |
| French, A | 1 |
| Little, C | 1 |
| Swift, S | 1 |
| Smith, S | 1 |
| Patteson, M | 1 |
4 trials available for pimobendan and Heart Valve Diseases
4 other studies available for pimobendan and Heart Valve Diseases
| Article | Year |
|---|---|
Echocardiographic evaluation of regurgitant fraction in dogs with subclinical myxomatous mitral valve disease: Method comparison, effects of pimobendan, and reproducibility.
Topics: Animals; Dog Diseases; Dogs; Echocardiography; Heart Valve Diseases; Mitral Valve; Reproducibility o | 2023 |
Effect of pimobendan on left atrial function in dogs with preclinical myxomatous mitral valve disease.
Topics: Animals; Atrial Function, Left; Cardiotonic Agents; Dog Diseases; Dogs; Female; Heart Valve Diseases | 2020 |
Valvular dysplasia and congestive heart failure in a juvenile African penguin (Spheniscus demersus).
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Zoo; Bird Diseases; Cardiotonic Agents; | 2014 |
Investigation of pimobendan versus benazepril in canine myxomatous valvular disease.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Cardiotonic Agents; Clinical Trials | 2003 |